HIVAIDS communities and AIDS vaccine research

1
HIV/AIDS communities and AIDS vaccine research

• AIDES / TRT-5
• Tour Essor
• 14, rue Scandicci
• 93508 Pantin Cedex

2
Questions from the community

• ANRS and vaccine trials of therapeutic vaccines
• ANRS and recruitment of HIV-volunteers to
  participate to vaccine trials (safety issues
  raised)
• Partnership with African NGOs (Réseau Afrique
  2000) how far are we from a vaccine?
• To stop the spread of AIDS

3
To be better informed

• TRT-5 first met
• with the ANRS investigators (1999)
• Aventis (Alvac) in 1999
• Attendance to scientific meetings
• Internal training sessions (immunologists)

4
To inform(articles in our newsletters)
5
To inform(training sessions in Africa)
6
To inform(symposium on immunology)
7
To inform

• Press releases after the announcement of the
  results of the ANRS trials
• Press release after AIDSVAX results

8
To link up

• Vaccine Working Group
• IAVI partnership
• Microbicides initiative

9
To work with

• ANRS
• AC5 Clinical trials to have two community
  representatives (voting rights)
• AC28 Preventive vaccines two community
  representatives (one from the HIV community and
  one from the volunteers)
• Modification of design of clinical trials
• Set up of the long term follow up of vaccinees

10
To lobby

• Towards the Industry to have access to vaccine
  preparation (Aventis supplied Orvéac with ALVAC
  after a TRT-5 meeting)
• Authorities to maintain a strong commitment to
  prolong the ANRS
• Within the ANRS, AC28 to finally do a proper
  work!

11
To lobby

• Within our organization for preventive
  technologies to be a priority
• EU for commitment
• French government to pursue funding for a
  preventive vaccine. Does it have to be only
  directed to the ANRS?